Abbott Laboratories
ABT133.550USD
+0.250+0.19%
종가 09/26, 16:00（ET）시세는 15분 지연됩니다
232.44B시가총액
16.63P/E TTM
자세한 내용은 Abbott Laboratories 회사
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
회사 정보
종목 코드 ABT
회사 이름Abbott Laboratories
상장일Mar 01, 1937
CEOMr. Robert B. Ford
직원 수114000
유형Ordinary Share
회계 연도 종료Mar 01
주소100 Abbott Park Road
도시ABBOTT PARK
증권 거래소NYSE Consolidated
국가United States of America
우편 번호60064-3500
전화12246676100
웹사이트https://www.abbott.com
종목 코드 ABT
상장일Mar 01, 1937
CEOMr. Robert B. Ford
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-0.40%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
50.97K
-0.75%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
+4.17%
Ms. Nancy Mckinstry
Ms. Nancy Mckinstry
Lead Independent Director
Lead Independent Director
38.72K
+4.41%
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
34.06K
-2.76%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.73M
+0.02%
Mr. Hubert L. Allen
Mr. Hubert L. Allen
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
191.90K
+3.84%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
133.77K
+6.42%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
95.58K
-0.82%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
71.93K
--
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
66.61K
-0.40%
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Diabetes Care
1.83B
17.64%
Core Laboratory
1.18B
11.36%
Adult Nutritionals
1.10B
10.67%
Pediatric Nutritionals
1.04B
10.05%
Key Emerging Markets
965.00M
9.32%
기타
4.24B
40.96%
지역별USD
이름
수익
비율
All other Countries
6.19B
59.76%
United States
4.17B
40.24%
사업별
지역별
사업별USD
이름
수익
비율
Diabetes Care
1.83B
17.64%
Core Laboratory
1.18B
11.36%
Adult Nutritionals
1.10B
10.67%
Pediatric Nutritionals
1.04B
10.05%
Key Emerging Markets
965.00M
9.32%
기타
4.24B
40.96%
주식 보유 통계
마지막 업데이트: Fri, Aug 15
마지막 업데이트: Fri, Aug 15
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
5.09%
State Street Global Advisors (US)
4.50%
Capital International Investors
3.46%
Capital Research Global Investors
2.40%
기타
74.67%
주주
주주
비율
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
5.09%
State Street Global Advisors (US)
4.50%
Capital International Investors
3.46%
Capital Research Global Investors
2.40%
기타
74.67%
주주 유형
주주
비율
Investment Advisor
46.40%
Investment Advisor/Hedge Fund
23.17%
Research Firm
3.60%
Bank and Trust
2.24%
Pension Fund
2.21%
Sovereign Wealth Fund
1.37%
Insurance Company
1.06%
Individual Investor
0.48%
Hedge Fund
0.44%
기타
19.02%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
4616
1.41B
81.28%
+6.94M
2025Q1
4644
1.42B
81.42%
+12.91M
2024Q4
4535
1.39B
80.22%
+15.89M
2024Q3
4391
1.36B
78.29%
-11.85M
2024Q2
4400
1.36B
78.24%
-7.03M
2024Q1
4402
1.35B
77.67%
-9.71M
2023Q4
4429
1.35B
77.56%
-11.05M
2023Q3
4298
1.34B
77.39%
-25.33M
2023Q2
4297
1.35B
77.60%
-13.55M
2023Q1
4281
1.35B
77.46%
-8.61M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
169.07M
9.72%
+1.18M
+0.70%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
87.82M
5.05%
+752.19K
+0.86%
Mar 31, 2025
State Street Global Advisors (US)
77.66M
4.46%
+497.07K
+0.64%
Mar 31, 2025
Capital International Investors
66.82M
3.84%
-1.15M
-1.69%
Mar 31, 2025
Capital Research Global Investors
50.73M
2.92%
-3.36M
-6.22%
Mar 31, 2025
Geode Capital Management, L.L.C.
36.90M
2.12%
+1.23M
+3.46%
Mar 31, 2025
JP Morgan Asset Management
28.80M
1.66%
+3.67M
+14.58%
Mar 31, 2025
Wellington Management Company, LLP
29.76M
1.71%
+3.37M
+12.77%
Mar 31, 2025
Norges Bank Investment Management (NBIM)
20.98M
1.21%
+626.72K
+3.08%
Dec 31, 2024
Wells Fargo Advisors
15.42M
0.89%
+165.54K
+1.09%
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Tue, Sep 2
마지막 업데이트: Tue, Sep 2
이름
비율
iShares U.S. Medical Devices ETF
16.79%
Goldman Sachs Future Health Care Equity ETF
6.3%
GMO US Quality ETF
5.19%
Invesco Pharmaceuticals ETF
4.64%
Polen Capital Global Growth ETF
4.64%
iShares U.S. Healthcare ETF
4.45%
Proshares Ultra Health Care
4.45%
Health Care Select Sector SPDR Fund
4.38%
AdvisorShares Focused Equity ETF
4.37%
Tema Heart & Health ETF
4.31%
더 보기
iShares U.S. Medical Devices ETF
비율16.79%
Goldman Sachs Future Health Care Equity ETF
비율6.3%
GMO US Quality ETF
비율5.19%
Invesco Pharmaceuticals ETF
비율4.64%
Polen Capital Global Growth ETF
비율4.64%
iShares U.S. Healthcare ETF
비율4.45%
Proshares Ultra Health Care
비율4.45%
Health Care Select Sector SPDR Fund
비율4.38%
AdvisorShares Focused Equity ETF
비율4.37%
Tema Heart & Health ETF
비율4.31%
주식 배당금
지난 5년 동안 총
16.46B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Dec 13, 2024
ABT.NB Interim Cash Dividend of gross USD 0.59 paid on Feb 14, 2025 going ex on Jan 15, 2025 with reinvestment option
Jan 15, 2025
Feb 14, 2025
Jan 15, 2025
Sep 19, 2024
ABT.NB Final Cash Dividend of gross USD 0.55 paid on Nov 15, 2024 going ex on Oct 15, 2024
Oct 15, 2024
Nov 15, 2024
Oct 15, 2024
Jun 15, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Aug 15, 2024 going ex on Jul 15, 2024 with reinvestment option
Jul 15, 2024
Aug 15, 2024
Jul 15, 2024
Feb 16, 2024
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on May 15, 2024 going ex on Apr 12, 2024
Apr 15, 2024
May 15, 2024
Apr 12, 2024
Dec 15, 2023
ABT.NB Interim Cash Dividend of gross USD 0.55 paid on Feb 15, 2024 going ex on Jan 11, 2024 with reinvestment option
Jan 12, 2024
Feb 15, 2024
Jan 11, 2024
Sep 21, 2023
ABT.NB Final Cash Dividend of gross USD 0.51 paid on Nov 15, 2023 going ex on Oct 12, 2023 with reinvestment option
Oct 13, 2023
Nov 15, 2023
Oct 12, 2023
Jun 09, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 15, 2023 going ex on Jul 13, 2023 with reinvestment option
Jul 14, 2023
Aug 15, 2023
Jul 13, 2023
Feb 17, 2023
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on May 15, 2023 going ex on Apr 13, 2023 with reinvestment option
Apr 14, 2023
May 15, 2023
Apr 13, 2023
Dec 09, 2022
ABT.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 15, 2023 going ex on Jan 12, 2023 with reinvestment option
Jan 13, 2023
Feb 15, 2023
Jan 12, 2023
Sep 15, 2022
ABT.NB Final Cash Dividend of gross USD 0.47 paid on Nov 15, 2022 going ex on Oct 13, 2022 with reinvestment option
Oct 14, 2022
Nov 15, 2022
Oct 13, 2022
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
